You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Effector T cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Munich (Bone marrow aspiration from the iliac crest, Illinois bone marrow aspiration neddle)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Bone marrow aspiration from the iliac crest
  • Illinois bone marrow aspiration neddle
  • Munich, Germany
    Division of Thoracic Surgery, Technical University of Munich, Mu
May 16, 2022

Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

Recruiting
  • Refractory Acute Myeloid Leukemia
  • +4 more
  • CD371-YSNVZ-IL18 CAR T cells
  • Basking Ridge, New Jersey
  • +6 more
Aug 29, 2023

Immunophenotyping of Blast Cells and Immune Effector Cells in

Completed
  • Leukemia
  • Blood and Marrow sample
  • Marseille, France
    Assistance Publique - Hopitaux de Marseille
Jan 23, 2023

Immunophenotyping of Plasma Cells and Immune Effector Cells in

Not yet recruiting
  • Multiple Myeloma
  • Biological sampling
  • (no location specified)
Jun 17, 2022

Influenza, Healthy Trial in Stanford (Fluzone®, FluMist®)

Completed
  • Influenza
  • Healthy
  • Fluzone®
  • FluMist®
  • Stanford, California
    Stanford University
Feb 11, 2020

Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

Not yet recruiting
  • Multiple Myeloma
  • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
  • +3 more
  • (no location specified)
Jul 28, 2023

EEG Encephalopathy Patterns in Immune Effectors Cells-associated

Completed
  • Immune Effector Cell Encephalopathy
  • Neurotoxicity
    • Montpellier, France
      Uhmontpellier
    Apr 11, 2022

    Cytokine Release Syndrome Trial in United States (Itacitinib, Immune effector cell therapy, Placebo)

    Recruiting
    • Cytokine Release Syndrome
    • Miami, Florida
    • +9 more
    Oct 25, 2022

    Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

    Not yet recruiting
    • Hematologic Malignancy
    • +5 more
    • autologous hematopoietic stem cells added to planned CAR T
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 31, 2023

    Multiple Myeloma Trial in Wuhan (Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells)

    Recruiting
    • Multiple Myeloma
    • Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 11, 2023

    Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

    Not yet recruiting
    • Head and Neck Cancer
    • +3 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Oct 18, 2023

    Human Papillomavirus-Related Malignant Tumor Trial in Wuhan (T512)

    Recruiting
    • Human Papillomavirus-Related Malignant Neoplasm
    • T512
    • Wuhan, Hubei, China
      Tongji Hospital
    Dec 29, 2021

    T-bet B Cells in Persistent Virus Control After Discontinuance

    Completed
    • Chronic HBV Infection
    • Drug Withdrawal
    • T-bet B cell
    • Shanghai, China
      Changhai hospital
    Sep 1, 2023

    Platinum-Resistant Ovarian Carcinoma Trial in Duarte (Chimeric Antigen Receptor T-cells, Cyclophosphamide, Fludarabine)

    Recruiting
    • Platinum-Resistant Ovarian Carcinoma
    • Chimeric Antigen Receptor T-cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jul 21, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix (Autologous MUC1-activated T-cells,

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Phoenix, Arizona
      Mayo Clinic Hospital in Arizona
    Jan 4, 2023

    Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

    Recruiting
    • Refractory Multiple Myeloma
    • Relapsed Multiple Myeloma
    • Manufactured Anti-BCMA CAR-T cells
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

    Withdrawn
    • T-cell Acute Lymphoblastic Leukemia
    • T-lymphoblastic Lymphoma
    • Target CD7 CAR-T cells
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Nov 23, 2022

    Advanced Sarcoma Trial (NKG2D-CAR memory T cell)

    Not yet recruiting
    • Advanced Sarcoma
    • NKG2D-CAR memory T cell
    • (no location specified)
    Oct 17, 2023

    High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

    Not yet recruiting
    • High Grade B-Cell Non-Hodgkin's Lymphoma
    • +3 more
    • Anti-CD19-CAR CMV-specific T-lymphocytes
    • +9 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    T-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CAR-T/CTL and DCvac)

    Recruiting
    • T-Cell Acute Lymphoblastic Leukemia
    • Antigen-specific T cells CAR-T/CTL and DCvac
    • Shenzhen, Guangdong, China
      Shenzhen Geno-immune Medical Institute
    Mar 14, 2022

    Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • iC9.GD2.CAR.IL-15 T Infusion
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Nov 16, 2022

    Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • iC9-CAR19 cells
    • +3 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Dec 21, 2022

    Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

    Recruiting
    • Pancreatic Cancer
    • TCR-T Cells Injection（GB3010 Cells Injection）
    • ShangHai, Shanghai, China
      Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
    Sep 19, 2023

    Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)

    Recruiting
    • Lymphoma
    • +4 more
    • iC9-CAR19 T cells
    • +4 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Dec 2, 2022

    Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

    Recruiting
    • Relapse/Refractory Multiple Myeloma
    • DeepTag-GPRC5D Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 10, 2023